{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:34:26Z","timestamp":1774074866866,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73777-y","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:02:40Z","timestamp":1729695760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relevance of 123I-FP-CIT SPECT prescriptions for the diagnosis of parkinsonian syndromes"],"prefix":"10.1038","volume":"14","author":[{"given":"Marion","family":"Houot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souraya","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Mongin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Pop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u00ebl","family":"Soussan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Lannuzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Degos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"73777_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord.30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"73777_CR2","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.27362","volume":"33","author":"RB Postuma","year":"2018","unstructured":"Postuma, R. B. et al. Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 33, 1601\u20131608 (2018).","journal-title":"Mov. Disord."},{"key":"73777_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2018.03.030","volume":"54","author":"V Fleury","year":"2018","unstructured":"Fleury, V., Brindel, P., Nicastro, N. & Burkhard, P. R. Descriptive epidemiology of parkinsonism in the canton of Geneva, Switzerland. Parkinsonism Relat. Disord. 54, 30\u201339 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"73777_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","volume":"62","author":"MC de Rijk","year":"1997","unstructured":"de Rijk, M. C. et al. Prevalence of parkinsonism and Parkinson\u2019s disease in Europe: the EUROPARKINSON collaborative study. European community concerted action on the epidemiology of Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 62, 10\u201315 (1997).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"73777_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamaneurol.2013.114","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica, R., Grossardt, B. R., Bower, J. H., Ahlskog, J. E. & Rocca, W. A. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol. 70, 859\u2013866 (2013).","journal-title":"JAMA Neurol."},{"key":"73777_CR6","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1212\/WNL.52.6.1214","volume":"52","author":"JH Bower","year":"1999","unstructured":"Bower, J. H., Maraganore, D. M., McDonnell, S. K. & Rocca, W. A. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976\u20131990. Neurology 52, 1214\u20131220 (1999).","journal-title":"Neurology"},{"key":"73777_CR7","first-page":"1129","volume":"37","author":"A Abi-Dargham","year":"1996","unstructured":"Abi-Dargham, A. et al. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT. J. Nucl. Med. 37, 1129\u20131133 (1996).","journal-title":"J. Nucl. Med."},{"key":"73777_CR8","first-page":"1879","volume":"39","author":"J Booij","year":"1998","unstructured":"Booij, J. et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson\u2019s disease. J. Nucl. Med. 39, 1879\u20131884 (1998).","journal-title":"J. Nucl. Med."},{"key":"73777_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer, T. S. et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov. Disord. 15, 503\u2013510 (2000).","journal-title":"Mov. Disord."},{"key":"73777_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/mds.20748","volume":"21","author":"M Lorberboym","year":"2006","unstructured":"Lorberboym, M. et al. [123I]-FP\/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson\u2019s disease. Mov. Disord. 21, 510\u2013514 (2006).","journal-title":"Mov. Disord."},{"key":"73777_CR11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/mds.22098","volume":"23","author":"M Tinazzi","year":"2008","unstructured":"Tinazzi, M. et al. [123I]FP-CIT SPET imaging in drug-induced Parkinsonism. Mov. Disord. 23, 1825\u20131829 (2008).","journal-title":"Mov. Disord."},{"key":"73777_CR12","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/ene.12444","volume":"21","author":"F Brigo","year":"2014","unstructured":"Brigo, F., Matinella, A., Erro, R. & Tinazzi, M. [123I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson\u2019s disease and vascular or drug-induced parkinsonisms: A meta-analysis. Eur. J. Neurol. 21, 1369-e90 (2014).","journal-title":"Eur. J. Neurol."},{"key":"73777_CR13","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/mds.21062","volume":"21","author":"C Gaig","year":"2006","unstructured":"Gaig, C. et al. 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism. Mov. Disord. 21, 1994\u20131998 (2006).","journal-title":"Mov. Disord."},{"key":"73777_CR14","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1007\/s00415-018-9029-y","volume":"265","author":"G Allali","year":"2018","unstructured":"Allali, G., Garibotto, V., Mainta, I. C., Nicastro, N. & Assal, F. Dopaminergic imaging separates normal pressure hydrocephalus from its mimics. J. Neurol. 265, 2434\u20132441 (2018).","journal-title":"J. Neurol."},{"issue":"Suppl 7","key":"73777_CR15","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1002\/mds.10576","volume":"18","author":"DC Costa","year":"2003","unstructured":"Costa, D. C., Walker, Z., Walker, R. W. H. & Fontes, F. R. G. Dementia with Lewy bodies versus Alzheimer\u2019s disease: Role of dopamine transporter imaging. Mov. Disord. 18(Suppl 7), S34-38 (2003).","journal-title":"Mov. Disord."},{"key":"73777_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith, I. et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: A phase III, multicentre study. Lancet Neurol. 6, 305\u2013313 (2007).","journal-title":"Lancet Neurol."},{"key":"73777_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13550-015-0087-1","volume":"5","author":"SR Suwijn","year":"2015","unstructured":"Suwijn, S. R. et al. The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson\u2019s disease or clinically uncertain parkinsonism: A systematic review. EJNMMI Res. 5, 12 (2015).","journal-title":"EJNMMI Res."},{"key":"73777_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ene.12022","volume":"20","author":"A Berardelli","year":"2013","unstructured":"Berardelli, A. et al. EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson\u2019s disease. Eur J Neurol. 20, 16\u201334 (2013).","journal-title":"Eur J Neurol."},{"key":"73777_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1212\/WNL.0000000000200786","volume":"99","author":"JP Seibyl","year":"2022","unstructured":"Seibyl, J. P. & Kuo, P. What is the role of dopamine transporter imaging in Parkinson prevention clinical trials?. Neurology 99, 61\u201367 (2022).","journal-title":"Neurology"},{"key":"73777_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00415-014-7634-y","volume":"262","author":"C Thiriez","year":"2015","unstructured":"Thiriez, C. et al. Clinical routine use of dopamine transporter imaging in 516 consecutive patients. J. Neuro. 262, 909\u2013915 (2015).","journal-title":"J. Neuro."},{"key":"73777_CR21","doi-asserted-by":"publisher","first-page":"e925130","DOI":"10.12659\/MSM.925130","volume":"26","author":"M Arjona","year":"2020","unstructured":"Arjona, M., Toldo, J. M. P., Carvalho, Q. N. & Pedroso, J. L. A real-world study of cerebral 99mTc-TRODAT-1 single-photon emission computed tomography (SPECT) imaging of the dopamine transporter in patients with Parkinson disease from a tertiary hospital in Brazil. Med. Sci. Monit. 26, e925130 (2020).","journal-title":"Med. Sci. Monit."},{"key":"73777_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/mdc3.14055","volume":"11","author":"S Quintas","year":"2024","unstructured":"Quintas, S., Sanles-Falagan, R. & Berb\u00eds, M. \u00c1. I(123)-FP-CIT (DaTSCAN) SPECT beyond the most common causes of parkinsonism: A systematic review. Mov. Disord. Clin. Pract. 11, 613\u2013625 (2024).","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"1","key":"73777_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41531-021-00185-8","volume":"7","author":"S Bega","year":"2021","unstructured":"Bega, S. et al. Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome\u00a0: A systematic review and meta-analysis. NPJ Parkinson\u2019s Dis. 7(1), 43 (2021).","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"73777_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5603\/PJNNS.a2019.0011","volume":"53","author":"A Gajos","year":"2019","unstructured":"Gajos, A. et al. Should non-movement specialists refer patients for SPECT-DaTSCAN?. Neurol. Neurochir. Pol. 53, 138\u2013143 (2019).","journal-title":"Neurol. Neurochir. Pol."},{"key":"73777_CR25","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0","volume":"15","author":"W Pirker","year":"2000","unstructured":"Pirker, W. et al. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov. Disord. 15, 1158\u20131167 (2000).","journal-title":"Mov. Disord."},{"key":"73777_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/mds.1256","volume":"16","author":"A Varrone","year":"2001","unstructured":"Varrone, A., Marek, K. L., Jennings, D., Innis, R. B. & Seibyl, J. P. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson\u2019s disease and multiple system atrophy. Mov. Disord. 16, 1023\u20131032 (2001).","journal-title":"Mov. Disord."},{"key":"73777_CR27","doi-asserted-by":"crossref","unstructured":"Parkinson Study Group. A multicenter assessment of dopamine transporter imaging with DOPASCAN\/SPECT in parkinsonism. Neurology. 55, 1540\u20131547. (2000).","DOI":"10.1212\/WNL.55.10.1540"},{"key":"73777_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"73777_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman, S. et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71, 670\u2013676 (2008).","journal-title":"Neurology"},{"key":"73777_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger, G. U. et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov. Disord. 32, 853\u2013864 (2017).","journal-title":"Mov. Disord."},{"key":"73777_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496\u2013503 (2013).","journal-title":"Neurology"},{"key":"73777_CR32","doi-asserted-by":"publisher","first-page":"e209453","DOI":"10.1212\/WNL.0000000000209453","volume":"102","author":"A Hastings","year":"2024","unstructured":"Hastings, A. et al. Neuropathologic validation and diagnostic accuracy of presynaptic dopaminergic imaging in the diagnosis of parkinsonism. Neurology 102, e209453 (2024).","journal-title":"Neurology."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73777-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:07:57Z","timestamp":1729696077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73777-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73777"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73777-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25088"}}